Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Photodermatol Photoimmunol Photomed ; 37(3): 202-213, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-33259115

RESUMEN

BACKGROUND AND PURPOSE: We hypothesized that upon sun exposure, a sub-population of primary skin-derived mesenchymal-like cells is deleteriously affected and thus contribute to the chronic inflammatory state in autosomal recessive variegate porphyria patients. The aim of this study was to isolate and characterize the mesenchymal-like stem cells from different areas of the skin in a porphyria patient (sun exposed, SE, and sun protected, SP) and to compare them with cells from a healthy individual. METHODS: The proliferation rate and the migration ability of SE and SP cells were evaluated in the presence of an antioxidant compound, N-acetylcysteine. A co-culture of SE-damaged cells with the conditioned medium from the enriched mesenchymal cell-like SP population was performed in order to regenerate the dermal injured tissue after sun exposure in patients. RESULTS: Results showed that the percentage of CD105+ cells varies between 3.9% in SP and 5% in SE of the healthy individual and between 3.6% and 1.4% in SP and SE in the porphyria patient, respectively. The osteogenic differentiation potential was lower in the porphyria patient when compared to the control. Furthermore, the expression of stem cell markers was more pronounced in SE than in SP cells of both control and porphyria. The use of N-acetyl cysteine did not show any beneficial effects on porphyria SE cells. Treatment with SP-conditioned medium slightly increased the expression of stem cell markers in SE of porphyria patient. CONCLUSION: In conclusion, the pool of mesenchymal stem-like SE cells is affected in variegate porphyria patient along with modification of their self-renewal and differentiation properties.


Asunto(s)
Células Madre Mesenquimatosas , Porfiria Variegata , Porfirias , Enfermedades de la Piel , Medios de Cultivo Condicionados , Humanos , Osteogénesis
2.
Stem Cells ; 32(6): 1459-67, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24302443

RESUMEN

Identification of molecular mechanisms involved in generation of different types of adipocytes is progressing substantially in mice. However, much less is known regarding characterization of brown (BAP) and white adipocyte progenitors (WAPs) in humans, highlighting the need for an in vitro model of human adipocyte development. Here, we report a procedure to selectively derive BAP and WAPs from human-induced pluripotent stem cells. Molecular characterization of APs of both phenotypes revealed that BMP4, Hox8, Hoxc9, and HoxA5 genes were specifically expressed in WAPs, whereas expression of PRDM16, Dio2, and Pax3 marked BAPs. We focused on Pax3 and we showed that expression of this transcription factor was enriched in human perirenal white adipose tissue samples expressing UCP1 and in human classical brown fat. Finally, functional experiments indicated that Pax3 was a critical player of human AP fate as its ectopic expression led to convert WAPs into brown-like APs. Together, these data support a model in which Pax3 is a new marker of human BAPs and a molecular mediator of their fate. The findings of this study could lead to new anti-obesity therapies based on the recruitment of APs and constitute a platform for investigating in vitro the developmental origins of human white and brown adipocytes.


Asunto(s)
Adipocitos Marrones/citología , Adipocitos Blancos/citología , Diferenciación Celular , Células Madre Pluripotentes Inducidas/citología , Factores de Transcripción Paired Box/metabolismo , Adipocitos Marrones/efectos de los fármacos , Adipocitos Marrones/metabolismo , Adipocitos Blancos/efectos de los fármacos , Adipocitos Blancos/metabolismo , Adipogénesis/efectos de los fármacos , Anciano de 80 o más Años , Animales , Diferenciación Celular/efectos de los fármacos , Femenino , Humanos , Células Madre Pluripotentes Inducidas/efectos de los fármacos , Células Madre Pluripotentes Inducidas/metabolismo , Masculino , Ratones , Factor de Transcripción PAX3 , Fenotipo , Tretinoina/farmacología
3.
Biochem Biophys Res Commun ; 430(3): 871-5, 2013 Jan 18.
Artículo en Inglés | MEDLINE | ID: mdl-23268339

RESUMEN

Human adipose-derived stem cell populations express cell surface markers such as CD105, CD73, CD146 and CD140a/PDFGRα. However, it was unclear whether these markers could discriminate subpopulations of undifferentiated cells and whether the expression of these markers is modulated during differentiation. To address this issue, we analysed the immunophenotype of cultured human multipotent adipose derived stem (hMADS) cell populations at different adipocyte differentiation steps. We found that 100% of undifferentiated cells expressed CD73 and CD105. In contrast, CD146 and CD140a/PDFGRα marked two different subpopulations of cells. CD140a/PDGFRα subpopulation was regulated by FGF2, a critical factor of human adipose-derived stem cell self-renewal. During differentiation, CD73 was maintained and marked lipid-laden cells, whereas CD105 expression was inhibited in fully differentiated cells. The percentage of CD146 and CD140a/PDFGRα-positive cells declined as soon as cells had undergone differentiation. Altogether, these data support the notion that expanded adipose-derived stem cells are heterogeneous mixtures of cells and cell surface markers studied can discriminate subpopulations.


Asunto(s)
Adipocitos/citología , Adipogénesis/fisiología , Tejido Adiposo/citología , Membrana Celular/metabolismo , Células Madre/citología , 5'-Nucleotidasa/biosíntesis , 5'-Nucleotidasa/genética , Adipogénesis/efectos de los fármacos , Tejido Adiposo/efectos de los fármacos , Antígenos CD/biosíntesis , Antígenos CD/genética , Biomarcadores/metabolismo , Antígeno CD146/biosíntesis , Antígeno CD146/genética , Línea Celular , Endoglina , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Factor 2 de Crecimiento de Fibroblastos/farmacología , Citometría de Flujo , Proteínas Ligadas a GPI/biosíntesis , Proteínas Ligadas a GPI/genética , Humanos , Receptor alfa de Factor de Crecimiento Derivado de Plaquetas/biosíntesis , Receptor alfa de Factor de Crecimiento Derivado de Plaquetas/genética , Receptores de Superficie Celular/biosíntesis , Receptores de Superficie Celular/genética
4.
J Lipid Res ; 51(8): 2352-61, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20410018

RESUMEN

The prevalence of obesity has steadily increased over the last few decades. During this time, populations of industrialized countries have been exposed to diets rich in fat with a high content of linoleic acid and a low content of alpha-linolenic acid compared with recommended intake. To assess the contribution of dietary fatty acids, male and female mice fed a high-fat diet (35% energy as fat, linoleic acid:alpha-linolenic acid ratio of 28) were mated randomly and maintained after breeding on the same diet for successive generations. Offspring showed, over four generations, a gradual enhancement in fat mass due to combined hyperplasia and hypertrophy with no change in food intake. Transgenerational alterations in adipokine levels were accompanied by hyperinsulinemia. Gene expression analyses of the stromal vascular fraction of adipose tissue, over generations, revealed discrete and steady changes in certain important players, such as CSF3 and Nocturnin. Thus, under conditions of genome stability and with no change in the regimen over four generations, we show that a Western-like fat diet induces a gradual fat mass enhancement, in accordance with the increasing prevalence of obesity observed in humans.


Asunto(s)
Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/metabolismo , Dieta , Grasas de la Dieta/farmacología , Mundo Occidental , Adipoquinas/sangre , Tejido Adiposo/citología , Animales , Peso Corporal/efectos de los fármacos , Femenino , Perfilación de la Expresión Génica , Humanos , Hiperplasia/etiología , Hiperplasia/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , Masculino , Ratones , Obesidad/etiología , Obesidad/metabolismo , Fenotipo , Células del Estroma/efectos de los fármacos , Células del Estroma/metabolismo , Factores de Tiempo , Ácido alfa-Linolénico/metabolismo , Ácido alfa-Linolénico/farmacología
5.
J Gastrointest Oncol ; 10(5): 859-868, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31602323

RESUMEN

BACKGROUND: Ferrochelatase (FECH) is the last enzyme of the heme biosynthesis pathway. Deficiency in FECH was associated with many diseases, including protoporphyria. Correlation studies showed that variations of FECH expression was detected in human carcinomas and more specifically in colon cancer. Nevertheless, the potential role of FECH in colon cancer carcinogenesis in vitro was not depicted yet. METHODS: A small interfering RNA (siRNA) was used to knockdown FECH in human Caco-2 colon cancer cells. The effect of FECH down-regulation on the cellular proliferation, the migration and the expression of target genes was assessed in cancer cells and compared to human normal fibroblasts. RESULTS: Following FECH down-regulation, our results demonstrated that the proliferation of Caco-2 cells was not affected. Furthermore, the migration of cancer and normal cells was affected, only when an additional stress factor (H2O2) was applied to the medium. The expression of twist, snail, hypoxia induced factor (HIF-1α) and vascular endothelial growth factor (VEGF) was reduced in Caco-2 cells. Conversely, VEGF and HIF-1α expression were upregulated by up to 2 folds in control fibroblasts. Interestingly, the pro-carcinogenic long noncoding RNA (LncRNA) H19 was 70% down-regulated in Caco-2 cells upon FECH down regulation whereas no effect was observed in normal fibroblasts. CONCLUSIONS: In conclusion, we showed that loss of FECH is protective against colon cancer tumorigenesis in vitro and this effect could possibly be mediated through inhibition of H19.

6.
Methods Mol Biol ; 1773: 31-39, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29687379

RESUMEN

In this chapter, we describe a protocol to induce at a high rate the differentiation of brown/brown like adipocyte progenitors (BAPs) derived from human induced pluripotent stem cells (hiPSCs). We also describe culture conditions to maintain hiPSCs and to derive hiPSC-BAPs.This novel culture system provides an unlimited source of human brown adipocytes and a unique means for studying events regulating the generation and recruitment of human BAPs.


Asunto(s)
Adipocitos Marrones/citología , Diferenciación Celular/efectos de los fármacos , Reprogramación Celular/efectos de los fármacos , Células Madre Pluripotentes Inducidas/citología , Amidas/farmacología , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Células Nutrientes/efectos de los fármacos , Fibroblastos/efectos de los fármacos , Humanos , Ratones , Mitomicina/farmacología , Piridinas/farmacología
7.
Obesity (Silver Spring) ; 22(8): 1830-7, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24753268

RESUMEN

OBJECTIVE: To characterize brown adipose tissue (BAT) in the human perirenal adipose tissue depot. METHOD: Perirenal adipose tissue biopsies were obtained from 55 healthy kidney donors. Expression analysis was performed using microarray, real-time PCR, immunoblotting and immunohistochemistry. Additional studies using human stem cells were performed. RESULTS: UCP1 gene expression analysis revealed a large intra-individual variation in the perirenal adipose tissue biopsies. Both multi- and unilocular UCP1-positive adipocytes were detected in several of the adipose tissue samples analyzed by immunohistochemical staining. Microarray analysis identified 54 genes that were overexpressed in UCP1-positive perirenal adipose tissue. Real-time PCR analysis of BAT candidate genes revealed a set of genes that were highly correlated to UCP1 and a set of three transcription factor genes (PRDM16, PGC1α, and RXRγ) that were highly correlated to each other. RXRγ displayed nuclear immunoreactivity in brown adipocytes and an increased gene expression during brown adipogenesis in human stem cells. CONCLUSION: Our data provides the first molecular characterization of BAT in the perirenal adipose tissue depot. Furthermore, it highlights the transcription factor RXRγ as a new player in BAT development.


Asunto(s)
Adipocitos Marrones/metabolismo , Tejido Adiposo Pardo/metabolismo , Canales Iónicos/metabolismo , Proteínas Mitocondriales/metabolismo , Receptor gamma X Retinoide/metabolismo , Adipogénesis , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Humanos , Inmunohistoquímica , Canales Iónicos/genética , Riñón , Proteínas Mitocondriales/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , Coactivador 1-alfa del Receptor Activado por Proliferadores de Peroxisomas gamma , Receptor gamma X Retinoide/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Proteína Desacopladora 1
8.
Am J Stem Cells ; 1(1): 42-7, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23671796

RESUMEN

Adipose tissue is an alternative source of mesenchymal stem cells and human adipose-derived stem cells (ASCs) display an attractive and substantial therapeutic potential when transplanted in animal models. To this end, an understanding of ASC biology is necessary and the knowledge of mechanisms that maintain ASCs in an undifferentiated state with no loss of differentiation potential during ex vivo expansion represents a crucial step. However, these mechanisms remain to be identified because appropriate human cellular models are scant. In this review we will describe a cellular model isolated from human adipose tissue displaying all the features of stem cells. Then, we will focus on the identification of intrinsic and extrinsic factors regulating the balance between human ASC proliferation and differentiation. We will point out the role of factors secreted by undifferentiated ASCs, such a FGF2, activin A, BMP4, Hedgehog molecules and secreted by adipose tissue macrophages. Finally, we will outline the role of miRNAs in these processes.

9.
Methods Mol Biol ; 702: 419-27, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21082419

RESUMEN

In this chapter, we describe a method to isolate and to expand multipotent adipose-derived stem (hMADS) cells from human adipose tissue. We also describe culture conditions to differentiate them into adipocytes at a high rate. This culture system provides a powerful means for studying the first steps of human adipose cell development and a route for investigating effects of drugs on the biology of adipocytes. Finally, we provide a protocol to investigate gene function during proliferation and differentiation of hMADS cells by means of siRNA-mediated gene silencing approaches or forced expression by transducing hMADS cells permissive to infection with murine retrovirus vectors.


Asunto(s)
Tejido Adiposo/citología , Técnicas de Cultivo de Célula/métodos , Células Madre Multipotentes/citología , Adipocitos/citología , Diferenciación Celular , Proliferación Celular , Separación Celular , Forma de la Célula , Congelación , Silenciador del Gen , Humanos , Células Madre Multipotentes/metabolismo , Células Madre Multipotentes/virología , Nitrógeno , ARN Interferente Pequeño/metabolismo , Retroviridae/genética , Transfección
10.
Cancer Lett ; 298(2): 264-72, 2010 Dec 08.
Artículo en Inglés | MEDLINE | ID: mdl-20702033

RESUMEN

Vascular endothelial growth factor is a potent pro-angiogenic growth factor which is also known to alter tumor microenvironment by inhibiting dendritic cell differentiation and promoting accumulation of myeloid-derived suppressor cells. In the present study, we analyzed the modifications induced by intratumoral expression of sFLT-1, a soluble VEGF receptor, in a rat metastatic colon carcinoma model. We generated colon cancer cell lines stably expressing sFLT-1 or a mock construct. Human umbilical vein endothelial cells cultured with conditioned medium from sFLT-1-expressing tumor cells exhibit a significantly decreased survival, demonstrating the functionality of the secreted sFLT-1. Invivo, sFLT-1 expression induced a 30% decrease in microvessel density in 15-day old experimental liver metastasis from colon carcinoma. Tumor growth was inhibited by 63% and 52% in left and right liver lobes respectively within 25days. In these tumors, sFLT-1 expression was associated with a decreased myeloid cell infiltration and a modification in the expression of several cytokines/chemokines. Altogether, these results suggest that VEGF trapping by sFLT-1 intratumoral expression results in reduced vascularization, tumor growth inhibition and modification of immune tumor microenvironment.


Asunto(s)
Neoplasias del Colon/metabolismo , Modelos Animales de Enfermedad , Neoplasias Hepáticas/metabolismo , Receptor 1 de Factores de Crecimiento Endotelial Vascular/metabolismo , Animales , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Quimiocinas/genética , Quimiocinas/metabolismo , Neoplasias del Colon/genética , Neoplasias del Colon/patología , Medios de Cultivo Condicionados/farmacología , Citocinas/genética , Citocinas/metabolismo , Células Endoteliales/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica , Humanos , Neoplasias Hepáticas/secundario , Masculino , Ratones , Células Mieloides/metabolismo , Células Mieloides/patología , Neovascularización Patológica/genética , Neovascularización Patológica/metabolismo , Neovascularización Patológica/patología , Ratas , Ratas Endogámicas , Transfección , Carga Tumoral , Receptor 1 de Factores de Crecimiento Endotelial Vascular/genética
11.
Diabetes ; 59(10): 2513-21, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20530742

RESUMEN

OBJECTIVE: Growth of white adipose tissue takes place in normal development and in obesity. A pool of adipose progenitors is responsible for the formation of new adipocytes and for the potential of this tissue to expand in response to chronic energy overload. However, factors controlling self-renewal of human adipose progenitors are largely unknown. We investigated the expression profile and the role of activin A in this process. RESEARCH DESIGN AND METHODS: Expression of INHBA/activin A was investigated in three types of human adipose progenitors. We then analyzed at the molecular level the function of activin A during human adipogenesis. We finally investigated the status of activin A in adipose tissues of lean and obese subjects and analyzed macrophage-induced regulation of its expression. RESULTS: INHBA/activin A is expressed by adipose progenitors from various fat depots, and its expression dramatically decreases as progenitors differentiate into adipocytes. Activin A regulates the number of undifferentiated progenitors. Sustained activation or inhibition of the activin A pathway impairs or promotes, respectively, adipocyte differentiation via the C/EBPß-LAP and Smad2 pathway in an autocrine/paracrine manner. Activin A is expressed at higher levels in adipose tissue of obese patients compared with the expression levels in lean subjects. Indeed, activin A levels in adipose progenitors are dramatically increased by factors secreted by macrophages derived from obese adipose tissue. CONCLUSIONS: Altogether, our data show that activin A plays a significant role in human adipogenesis. We propose a model in which macrophages that are located in adipose tissue regulate adipose progenitor self-renewal through activin A.


Asunto(s)
Activinas/fisiología , Tejido Adiposo/citología , Glucosafosfato Deshidrogenasa/genética , Obesidad Mórbida/patología , Células Madre/citología , Delgadez/patología , Activinas/genética , Activinas/farmacología , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/patología , Adulto , Diferenciación Celular , División Celular , ARN Polimerasas Dirigidas por ADN/efectos de los fármacos , ARN Polimerasas Dirigidas por ADN/genética , Dexametasona/farmacología , Regulación de la Expresión Génica , Glucosafosfato Deshidrogenasa/efectos de los fármacos , Humanos , Obesidad Mórbida/genética , Obesidad Mórbida/prevención & control , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Madre/efectos de los fármacos , Células Madre/patología , Proteína de Unión a TATA-Box/efectos de los fármacos , Proteína de Unión a TATA-Box/genética
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda